Inclacumab

Inclacumab
Monoclonal antibody
TypeWhole antibody
SourceHuman
Targetselectin P
Clinical data
Other namesLC1004-002
ATC code
  • none
Identifiers
CAS Number
ChemSpider
  • none
UNII
KEGG
Chemical and physical data
FormulaC6452H9930N1730O2024S42
Molar mass145465.02 g·mol−1

Inclacumab (LC1004-002) (INN) is a human monoclonal antibody designed for the treatment of cardiovascular disease.

The antibody is outlicensed by Roche.

This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.